2REINHARD G,MARTEN A,KISKE S M,et al.Generation of dendritic cell-based vaccines for cancer therapy[J].Br J Cancer,2002,86(10):1529 - 1533.
3DHODAPKAR M V,STEINMAN R M,KRASOVSKY J,et al.Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells[J].J Exp Med,2001,193(2):233- 238.
4THURNER B,RODER C,DIECKMANN D,et al.Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application[J].J Immunol Methods,1999,223 (1):1 -15.
5ARDESHNA K M,PIZZEY A R,DEVEREUX S,et al.The PI3 kinase,p38 SAP kinase,and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells [J].Blood,2000,96 (3):1039 -1046.
6LYAKH L A,KOSKI G K,TELFORD W,et al.Bacterial lipopolysaccharide,TNF-alpha,and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14 + monocytes through distinct pathways that activate NK-kappa B [J].J Immunol,2000,165(7):3647 -3655.
